# FDA Inspection 1176467 - Grifols Therapeutics LLC - May 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/22e93194-bc84-49e1-8de7-445532cdee68
Source feed: FDA_Inspections

> FDA Inspection 1176467 for Grifols Therapeutics LLC on May 06, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176467
- Company Name: Grifols Therapeutics LLC
- Inspection Date: 2022-05-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1302186 - 2026-02-05](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/34708a56-41e8-4e87-bab0-c702d71a2713)
- [FDA Inspection 1176467 - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9cf52920-d34b-4f87-840d-e52213631e5a)
- [FDA Inspection 1079999 - 2018-12-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a8c4df93-a1d3-415f-a6ee-5067a6f6675c)
- [FDA Inspection 994781 - 2016-10-21](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9a41f385-bd40-454e-bfcf-1cf95a896584)
- [FDA Inspection 879629 - 2014-04-01](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/3819503a-012b-4527-ae84-c8ec0475194b)

Company: https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d